Direct Relationship Between Uric Acid and C-Reactive Protein and Its Implication in the Chronic Kidney Disease

Jaya Jeena1, Sunita Manhas1, Rajendra Prasad1

  • 1Department of Biochemistry, MMIMSR, Mullana, Ambala, Haryana India.

Insights

Serum uric acid and C-Reactive protein (CRP) are elevated in chronic kidney disease (CKD) patients. These biomarkers show a strong direct relationship, suggesting they contribute to CKD progression.

Area of Science:

  • Nephrology
  • Clinical Biochemistry

Background:

  • Chronic Kidney Disease (CKD) presents a significant health burden in India, contributing to high morbidity and mortality.
  • A potential link between serum uric acid and C-Reactive protein (CRP) is implicated in CKD's pathological processes.

Purpose of the Study:

  • To investigate the relationship between serum uric acid and CRP levels in CKD patients.
  • To compare these levels between CKD patients and healthy controls.

Main Methods:

  • Serum uric acid and C-Reactive protein (CRP) were measured in 50 CKD patients (pre-dialysis) and 50 controls.
  • Quantitative turbidimetric immunoassay was used for CRP measurement.
  • Standard biochemical analyses were performed.

Main Results:

  • CKD patients exhibited significantly higher levels of serum uric acid, creatinine, urea, and CRP compared to controls.
  • CRP levels were notably higher in non-diabetic CKD patients than in diabetic CKD patients.
  • A Receiver Operating Characteristic (ROC) curve analysis revealed a strong association between uric acid and CRP.

Conclusions:

  • A significant direct correlation exists between serum uric acid and CRP in CKD patients.
  • Elevated levels of both uric acid and CRP are strongly associated with CKD progression.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
62
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
153
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
76
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
39
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
212
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
66